MTA (LY231514) demonstrates clinical activity against malignant mesothelioma in a phase I combination trial with carboplatin
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S285-S286
- https://doi.org/10.1016/s0959-8049(99)81566-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: